Oss-based biotech company Citryll bags €85M funding to fight inflammatory diseases: Here’s how
Oss, The Netherlands-based Citryll, a biotech company, announced on Monday that it has closed an oversubscribed €85M in a Series B funding round.
Popular topics
The economy of building technology — markets, startups, capital flows, and the operating decisions behind ambitious companies.
8,429 articles · Business
Oss, The Netherlands-based Citryll, a biotech company, announced on Monday that it has closed an oversubscribed €85M in a Series B funding round.
Nijmegen, The Netherlands-based Alveron Pharma, a clinical-stage company, announced on Monday that it has secured €5M in a Series Seed extension funding round led by Broadview Ventures.
"Startups are a marathon, not a sprint."
London-based Cerve, a provider of infrastructure and API solutions, announced on Thursday that it has secured £3.5M (approximately €4.2M) in a seed funding round led by B2B SaaS specialist VC, SuperSeed, with participation from Zenith, Ponderosa, and The First Thirty.
Berlin-based Fly Ventures, a VC that invests in seed-stage European startups, on Friday announced that it has closed its third fund at €80M.
San Sebastián, Spain-based Multiverse Computing, a quantum AI software company, has received an investment from CDP Venture Capital Sgr, Italy's largest venture capital investor.
Tampere, Finland-based Liquid Sun, a company specialised in creating sustainable fuels, announced that it has secured nearly €4M in funding from Voima Ventures, Failup, and Business Finland to build an eSAF (sustainable aviation fuel) demonstration unit.
Amsterdam-based Avantium, a company specialising in sustainable chemistry technologies, has raised €11.2M by selling 6,380,223 new shares.
Stockholm-based Talentium, an AI-powered hiring platform, has secured €3.5M in a pre-seed funding round.
As we come to take working from anywhere as a new norm, it is not easy to find remote job opportunities.
On Wednesday, Cambridge, UK-based 52North, the medtech company focused on transforming urgent care pathways in oncology, announced that it has secured $6M (approximately €5.7M) in a funding round.
In 2012, when I passed out of my engineering college, my first job gave me an immediate reality check - what I learned in college did not necessarily apply in the real world.